DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Referenz

Siegel D, Martin T, Nooka A. et al.
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies.

Haematologica 2013;
98 (11) 1753-1761

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: